Brief: Neubase Therapeutics To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets
23/02/2024 23:37
Feb 23 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS- ON FEB 22, BOARD DETERMINED FOR
COMPANY TO
DISSOLVE, LIQUIDATE AND DISTRIBUTE TO STOCKHOLDERS ITS AVAILABLE
ASSETS
* NEUBASE THERAPEUTICS INC - HAS BEEN ENGAGED IN AN
EVALUATION OF
POTENTIAL STRATEGIC AND OTHER ALTERNATIVES
* NEUBASE THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVED
LIQUIDATION AND DISSOLUTION OF COMPANY
* NEUBASE THERAPEUTICS INC - BOARD EXPECTS TO, IN NEAR
FUTURE
APPROVE A FORMAL PLAN OF DISSOLUTION
Source text for Eikon: ID:n0001104659-24-027005
Further company coverage: NBSE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet